PharmD, MS
PGY1 Pharmacy Practice Resident
In 2013, the FDA approved a new class of anti-diabetic medications called sodium-glucose cotransporter-2 (SGLT2) inhibitors. Insulin and metformin remain as preferred first-line agents for type-1 diabetes (T1D) and type-2 diabetes (T2D), respectively.1 However, due to their novel mechanism of action, SGLT2 inhibitors are an attractive second- or third-line option Read more…
Presented by: Dr. Eris Cani / Summarized by: Dr. Sarah Jung / Reviewed by: Dr. Stanley Moy HAPPY 2016!!! Summary: Procalcitonin is a specific biomarker that can be useful for diagnosing bacterial infections Most evidence for PCT utilization is for patients with LRTI (rule-in or rule-out pneumonia) Read more…
Hello everyone! I’d like to start off by saying it’s an honor to contribute to this amazing group! I am one of three pharmacy residents at SUNY Downstate Medical Center and have had the opportunity of working with some of you at UHB. Starting this month, I will be posting Read more…